About Rhogen
Rhogen is a Healthcare company based in Bengaluru (India) founded in 2020. Provider of therapeutics for life-threatning organ dysfunction. The company has 1 employees. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Bacterial. Its legal entity in India is Rhogenites Biotech India Private Limited (U73100KA2020PTC141399).
Company details
Rhogen was founded in 2020 and is based in Bengaluru, India. Focus is placed on the biotechnology sector, where recombinant protein fusion technology is utilized to create enzyme therapeutics. New insights into inflammatory responses are generated through this approach. Treatments targeting endotoxin-mediated sepsis and septic shock are developed to address organ dysfunction. Operations center on advancing therapeutic solutions for critical health conditions.
- Headquarters Bengaluru, India
- Employees 1
- SectorsHealthcare
- Website rhogen.com
- Social X
- Legal Name Rhogenites Biotech India Private Limited
- Date of Incorporation 24 Nov, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹5,925
FY 2025 · +17% YoY
- Net Loss-₹49.5 Lakh
FY 2025 · -83559% margin
- EBITDA-₹49 Lakh
FY 2025 · -82712% margin
- Employee Count1
Associated legal entities of Rhogen
Rhogen operates through Rhogenites Biotech India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rhogenites Biotech India Private Limited CIN U73100KA2020PTC141399 | Active | 24 Nov 2020 | Bangalore, Karnataka | ₹0.0 Cr | 2 | View details |
Board of directors of Rhogenites Biotech India Private Limited (Rhogen)
Rhogenites Biotech India Private Limited is the primary company behind Rhogen. The board of Rhogenites Biotech India Private Limited currently have 2 directors; the longest-serving is Karuppannan Poongodi Indira, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Karuppannan Poongodi Indira DIN 08971572 | Director | 24 Nov 2020 | 5 yrs 11 mo | Rhogenites Biotech India Private Limited |
| Karuppusamy Muthukumar DIN 06603672 | Director | 24 Nov 2020 | 5 yrs 11 mo | Rhogenites Biotech India Private Limited |
Financials of Rhogen
Figures of Rhogenites Biotech India Private Limited, the primary company behind Rhogen, for FY 2025. Revenue was ₹5,925 (+17% year on year). Net loss was -₹49.5 Lakh (-83559% margin). EBITDA was -₹49 Lakh (-82712% margin).
- ₹5,925Revenue · FY 2025 · +17% YoY
- -₹49.5 LakhNet loss · -83559% margin
- -₹49 LakhEBITDA · -82712% margin
- ₹42 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Rhogenites Biotech India Private Limited are on its company page.
Detailed financial statements for Rhogen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rhogen
Rhogen was founded in 2020.
Rhogen is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rhogen has 1 employees.
The primary company behind Rhogen, Rhogenites Biotech India Private Limited, reported revenue of ₹5,925 for FY 2025, up 17% year on year.
Rhogen was founded in 2020 and is based in Bengaluru, India. Focus is placed on the biotechnology sector, where recombinant protein fusion technology is utilized to create enzyme therapeutics. New insights into inflammatory responses are generated through this approach. Treatments targeting endotoxin-mediated sepsis and septic shock are developed to address organ dysfunction. Operations center on advancing therapeutic solutions for critical health conditions.
Rhogen operates through Rhogenites Biotech India Private Limited.
The legal entities of Rhogen currently have 2 directors, including Karuppannan Poongodi Indira, Karuppusamy Muthukumar.